Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Equities
BLCM
US0794814048
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | 6.2M | Sales 2022 | 1.5M | Capitalization | 822K |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -25M | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | 13 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 98.45% |
1st Jan change | Capi. | |
---|---|---|
-2.15% | 103B | |
+0.64% | 95.71B | |
+1.69% | 22.02B | |
-17.13% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.94% | 15.52B | |
+3.50% | 13.86B | |
+34.48% | 12.04B |